Publications by authors named "Louis Mauriac"

Claim this Profile
C
Comprehensive prognostic analysis in breast cancer integrating clinical, tumoral, micro-environmental and immunohistochemical criteria.
Isabelle de Mascarel, Marc Debled, Véronique Brouste, Louis Mauriac, Ghislaine Sierankowski

Springerplus· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer.
Nathalie Quenel-Tueux, Marc Debled, Justine Rudewicz, Gaetan MacGrogan, Marina Pulido, Louis Mauriac

Br J Cancer· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitude.
Marc Debled, Gaëtan MacGrogan, Christelle Breton-Callu, Stéphane Ferron, Gabrielle Hurtevent, Louis Mauriac

Eur J Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant endocrine treatment in breast cancer: analysis of daily practice in large cancer center to facilitate decision making.
Marc Debled, Gaël Auxepaules, Christine Tunon de Lara, Delphine Garbay, Véronique Brouste, Louis Mauriac

Am J Surg· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiofrequency ablation as a substitute for surgery in elderly patients with nonresected breast cancer: pilot study with long-term outcomes.
Jean Palussière, Corinne Henriques, Louis Mauriac, Maryam Asad-Syed, Fabienne Valentin

Radiology· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Meredith M Regan, Patrick Neven, Anita Giobbie-Hurder, Aron Goldhirsch, Bent Ejlertsen, Louis Mauriac

Lancet Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line chemotherapy for metastatic breast cancer in patients ≥75 years: a retrospective single-centre analysis.
Marc Debled, Nicolas Madranges, Cécile Mertens, Michel Durand, Véronique Brouste, Louis Mauriac

Crit Rev Oncol Hematol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial.
Hervé Bonnefoi, Martine Piccart, Jan Bogaerts, Louis Mauriac, Pierre Fumoleau

Lancet Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Medical treatments of endocrine-sensitive Her-2 negative breast cancers: a review].
Marc Debled, Florence Dalenc, Louis Mauriac, Etienne Brain

Bull Cancer· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients.
Christine Tunon-de-Lara, Gwenaëlle André, Gaétan Macgrogan, Jean-Marie Dilhuydy, Jean-Emmanuel Bussières, Louis Mauriac

Ann Surg Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study.
Marco Colleoni, Anita Giobbie-Hurder, Meredith M Regan, Beat Thürlimann, Henning Mouridsen, Louis Mauriac

J Clin Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction--Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.
Hervé Bonnefoi, Anil Potti, Mauro Delorenzi, Louis Mauriac, Mario Campone

Lancet Oncol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.
Jean-Marc Extra, Eric C Antoine, Anne Vincent-Salomon, Thierry Delozier, Pierre Kerbrat, Louis Mauriac

Oncologist· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2).
Kathleen I Pritchard, Janusz Rolski, Zsuzsanna Papai, Louis Mauriac, Fatima Cardoso

Breast Cancer Res Treat· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer?
Florence Ragage, Marc Debled, Gaëtan MacGrogan, Véronique Brouste, Marie Desrousseaux, Louis Mauriac

Cancer· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.
Francesco Sardanelli, Carla Boetes, Bettina Borisch, Thomas Decker, Massimo Federico, Louis Mauriac

Eur J Cancer· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer.
Marc Debled, Isabelle de Mascarel, Veronique Brouste, Louis Mauriac, Gaetan MacGrogan

J Natl Cancer Inst· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line capecitabine monotherapy for slowly progressing metastatic breast cancer: do we need aggressive treatment?
Marc Debled, Nicolas Madranges, Alexandra Trainaud, Anne Floquet, Catherine Donamaria, Louis Mauriac

Oncology· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of fulvestrant versus exemestane in advanced breast cancer patients with or without visceral metastases: data from the EFECT trial.
Louis Mauriac, Gilles Romieu, José Bines

Breast Cancer Res Treat· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.

N Engl J Med· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of HER2 gene status in Her2 2+ invasive breast cancer: a study of 108 cases comparing ASCO/CAP and FDA recommendations.
Frédéric Chibon, Isabelle de Mascarel, Ghislaine Sierankowski, Véronique Brouste, Hervé Bonnefoi, Louis Mauriac

Mod Pathol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D2-40 in breast cancer: should we detect more vascular emboli?
Isabelle de Mascarel, Gaëtan MacGrogan, Marc Debled, Ghislaine Sierankowski, Véronique Brouste, Louis Mauriac

Mod Pathol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epithelial atypia: a marker risk of concomitant or subsequent breast carcinoma?
Isabelle de Mascarel, Gaëtan MacGrogan, Anne Vincent-Salomon, Simone Mathoulin-Pélissier, Véronique Brouste, Louis Mauriac

J Clin Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.
Diana Crivellari, Zhuoxin Sun, Alan S Coates, Karen N Price, Beat Thürlimann, Louis Mauriac

J Clin Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.
Maïa Chanrion, Vincent Negre, Hélène Fontaine, Nicolas Salvetat, Frédéric Bibeau, Louis Mauriac

Clin Cancer Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis